Table 2. Postoperative adverse events were compared between the two groups.
| Acid inhibition group (n = 25) | Non-acid inhibition group (n = 20) | P | |
|---|---|---|---|
| Technical success | 100% | 100% | 1 |
| Clinical success | 23/25 (92%) | 18/20 (90%) | 1 |
| Infection | 13/25 (52%) | 9/20 (45%) | 0.641 |
| Bleeding | 5/25 (20%) | 3/20 (15%) | 0.965 |
| Recurrence | 7/25 (28%) | 1/20 (5%) | 0.107 |